Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q2 '25Q1 '25
$237.37M$49.86M$87.97M
$220.09M$113.67M$97.51M
$464M$169.43M$192.55M
$596K$648K$609K
$467.78M$175.26M$194.78M
$6.23M$5.68M+97.2%$5.73M$2.88M
$12.94M$13.19M$10.68M
$13.51M$13.71M$11.25M
-$228.7M-$204.55M-$181.86M
$454.27M+421%-$198.62M-53.8%-$176.64M-53.2%-$141.47M-$129.15M
$467.78M$175.26M$194.78M

FAQ

What are Hemab Therapeutics Holdings, Inc.'s total assets?
Hemab Therapeutics Holdings, Inc. (COAG) holds $467.8M in total assets.
How much debt does Hemab Therapeutics Holdings, Inc. have?
Hemab Therapeutics Holdings, Inc. carries $1.0M in total debt against $454.3M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Hemab Therapeutics Holdings, Inc. have?
Hemab Therapeutics Holdings, Inc. holds $237.4M in cash and equivalents.
Can Hemab Therapeutics Holdings, Inc. cover its short-term obligations?
Its current ratio is 35.85 — current assets exceed current liabilities.
Where does Hemab Therapeutics Holdings, Inc.'s balance sheet data come from?
Every line is extracted from Hemab Therapeutics Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.